Literature DB >> 27667586

Biosafety standards for working with Crimean-Congo hemorrhagic fever virus.

Manfred Weidmann1, Tatjana Avsic-Zupanc2, Silvia Bino3, Michelle Bouloy4, Felicity Burt5, Sadegh Chinikar6, Iva Christova7, Isuf Dedushaj8, Ahmed El-Sanousi9, Nazif Elaldi10, Roger Hewson11, Frank T Hufert12, Isme Humolli8, Petrus Jansen van Vuren13, Zeliha Koçak Tufan14, Gülay Korukluoglu15, Pieter Lyssen16, Ali Mirazimi17, Johan Neyts16, Matthias Niedrig18, Aykut Ozkul19, Anna Papa20, Janusz Paweska13, Amadou A Sall21, Connie S Schmaljohn22, Robert Swanepoel23, Yavuz Uyar24, Friedemann Weber25, Herve Zeller26.   

Abstract

In countries from which Crimean-Congo haemorrhagic fever (CCHF) is absent, the causative virus, CCHF virus (CCHFV), is classified as a hazard group 4 agent and handled in containment level (CL)-4. In contrast, most endemic countries out of necessity have had to perform diagnostic tests under biosafety level (BSL)-2 or -3 conditions. In particular, Turkey and several of the Balkan countries have safely processed more than 100 000 samples over many years in BSL-2 laboratories. It is therefore advocated that biosafety requirements for CCHF diagnostic procedures should be revised, to allow the tests required to be performed under enhanced BSL-2 conditions with appropriate biosafety laboratory equipment and personal protective equipment used according to standardized protocols in the countries affected. Downgrading of CCHFV research work from CL-4, BSL-4 to CL-3, BSL-3 should also be considered.

Entities:  

Mesh:

Year:  2016        PMID: 27667586     DOI: 10.1099/jgv.0.000610

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.

Authors:  Ravendra P Chauhan; Zelalem G Dessie; Ayman Noreddin; Mohamed E El Zowalaty
Journal:  Pathogens       Date:  2020-04-20

Review 2.  Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.

Authors:  Vanessa N Raabe
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

3.  A case of Crimean-Congo haemorrhagic fever imported in Greece: Contact tracing and management of exposed healthcare workers.

Authors:  Helena C Maltezou; Anna Papa; Sarantoula Ventouri; Charikleia Tseki; Danai Pervanidou; Androula Pavli; Periklis Panagopoulos; Philothei Markatou; Elpida Gavana; Efstratios Maltezos
Journal:  J Infect Prev       Date:  2019-06-06

Review 4.  A Comprehensive Review of Common Bacterial, Parasitic and Viral Zoonoses at the Human-Animal Interface in Egypt.

Authors:  Yosra A Helmy; Hosny El-Adawy; Elsayed M Abdelwhab
Journal:  Pathogens       Date:  2017-07-21

5.  Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach.

Authors:  Amanda Fritzen; Christian Risinger; Gulay Korukluoglu; Iva Christova; Arina Corli Hitzeroth; Natalie Viljoen; Felicity Jane Burt; Ali Mirazimi; Ola Blixt
Journal:  PLoS Negl Trop Dis       Date:  2018-07-09

6.  Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus.

Authors:  Touraj Aligholipour Farzani; Alireza Hanifehnezhad; Katalin Földes; Koray Ergünay; Erkan Yilmaz; Hiba Hashim Mohamed Ali; Aykut Ozkul
Journal:  Viruses       Date:  2019-01-17       Impact factor: 5.048

Review 7.  Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks.

Authors:  Barbara Bartolini; Cesare Em Gruber; Marion Koopmans; Tatjana Avšič; Sylvia Bino; Iva Christova; Roland Grunow; Roger Hewson; Gulay Korukluoglu; Cinthia Menel Lemos; Ali Mirazimi; Anna Papa; Maria Paz Sanchez-Seco; Aisha V Sauer; Hervè Zeller; Carla Nisii; Maria Rosaria Capobianchi; Giuseppe Ippolito; Chantal B Reusken; Antonino Di Caro
Journal:  Euro Surveill       Date:  2019-01

8.  Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet.

Authors:  Chantal B Reusken; Ramona Mögling; Pieter W Smit; Roland Grunow; Giuseppe Ippolito; Antonino Di Caro; Marion Koopmans
Journal:  Euro Surveill       Date:  2018-05

Review 9.  Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development.

Authors:  Thomas Tipih; Felicity Jane Burt
Journal:  Biores Open Access       Date:  2020-05-12

10.  Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies.

Authors:  Sultan Gülce-İz; Nazif Elaldı; Hüseyin Can; Esra Atalay Şahar; Muhammet Karakavuk; Aytül Gül; Gizem Örs Kumoğlu; Aysu Değirmenci Döşkaya; Adnan Yüksel Gürüz; Aykut Özdarendeli; Philip Louis Felgner; Huw Davies; Mert Döşkaya
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.